Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Part of paid clinical trials in Lakewood, California.
- Sponsor
- Gelb, Arthur F., M.D.
- Study ID
- NCT03263130
- Status
- Recruiting
Conditions
- COPD, Emphysema, Asthma COPD Overlap
- Emphysema
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap — OTHER
Study Details
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and PDE type 4 inhibitor. In some cases, the patient may have had a history of asthma preceding the development of COPD (Asthma COPD Overlap).
Key Dates
- Start date
- Jan 1, 2017
- Status verified
- Oct 2023
- Primary completion
- Jan 1, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: COPD, Emphysema, Asthma-COPD OverlapBased on clinical, pathologic, laboratory, physiologic and radiologic differences, patient groups can be described.
Primary Outcome Measure
Site and Mechanism(s) of Expiratory Airflow Limitation [ Time Frame: 4 years ]
Central Contacts
- Arthur F Gelb, MD562-633-2204
- Christine Fraser562-633-2204
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arthur F Gelb MD | Lakewood | California | 90712 | Arthur F Gelb, MD (PRINCIPAL_INVESTIGATOR) |
| Arthur F Gelb MD | Lakewood | California | 90712 |
Find similar trials in Lakewood, CA
Related Studies
- STRIVE Post-Market Registry StudyRecruiting · Olympus Corporation of the Americas · Phoenix, Arizona
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling By Invitation · Paragonix Technologies · Phoenix, Arizona
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3Recruiting · Apreo Health, Inc. · Birmingham, Alabama
- A Multi Center Study Testing a New Implant for Adults With Severe EmphysemaRecruiting · Pulmair Medical, Inc. · San Francisco, California